Skip to content

Apixaban (ATC B01AF02)

DRUG2 trials

Sponsors

Canadian Network for Observational Drug Effect Studies, CNODES

Conditions

All-cause MortalityAtrial FibrillationIschemic StrokeMajor BleedMyocardial InfarctionSystemic EmbolizationVenous Thromboembolism

Related Papers